Ginsenoside-Rg1 protects podocytes from complement mediated injury-Reference-Cited by-同舟云学术

Ginsenoside-Rg1 protects podocytes from complement mediated injury

Published:2011-09 Issue:1 Volume:137 Page:99-107
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Zhang Ming-Hua,Fan Jun-ming,Xie Xi-sheng,Deng Yue-yi,Chen Yi-pin,Zhen Rong,Li Jing,Cheng Yuan,Wen Ji

Funder

National Science and Technology Support Program of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference53 articles.

1. p38 mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury;Aoudjit;American Journal of Physiology Renal Physiology,2003

2. Studies of the inhibition of C56-induced lysis (reactive lysis) 4. Modulation of C56-induced lysis by polyanions and polycations;Baker;Journal of Immunology,1975

3. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1;Chen;British Journal of Pharmacology,2006

4. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress;Chen;Acta Pharmacologica Sinica,2005

5. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro;Chen;Kidney International,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenosides as dietary supplements with immunomodulatory effects: a review;Applied Biological Chemistry;2024-03-06

2. Downregulation of TRPC6 regulates ERK1/2 to prevent sublytic C5b‑9 complement complex‑induced podocyte injury through activating autophagy;Experimental and Therapeutic Medicine;2023-10-26

3. Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice;Biomedicine & Pharmacotherapy;2022-06

4. Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction;Cell Death & Disease;2022-03-29

5. The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition;Heliyon;2021-11